Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.34 |
| ▸ | NAAA | Q02083 | 2/20 | 0.31 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.31 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.31 |
| ▸ | TPSD1 | Q9BZJ3 | 1/20 | 0.31 |
| ▸ | TPSG1 | Q9NRR2 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2706509 | 0.87 | CYP2C19 (0.43) | CYP2C19EPHX1NAAAPRSS1TPSAB1 | |
| SCHEMBL7900879 | 0.85 | CYP2C19 (0.42) | CYP2C19EPHX1NAAAPRSS1TPSAB1 | |
| SCHEMBL181447 | 0.85 | CYP2C19 (0.46) | CYP2C19EPHX1NAAAPRSS1TPSAB1 | |
| SCHEMBL26276749 | 0.83 | CYP2C19 (0.44) | CYP2C19EPHX1NAAAPRSS1TPSAB1 | |
| SCHEMBL3781529 | 0.83 | CYP2C19 (0.49) | CYP2C19EPHX1NAAAPRSS1TPSAB1 | |
| Hydrochloric Acid SCHEMBL28854896 | 0.81 | CYP2C19 (0.43) | CYP2C19EPHX1NAAAPRSS1TPSAB1 | |
| SCHEMBL2734290 | 0.79 | CYP2C19 (0.41) | CYP2C19L3MBTL1EPHX1NAAACA1 | |
| SCHEMBL2725317 | 0.76 | CYP19A1 (0.33) | — | |
| SCHEMBL971209 | 0.75 | CYP3A4 (0.41) | CYP2C19L3MBTL1 | |
| SCHEMBL5361582 | 0.73 | SERPINE1 (0.32) | CYP2C19L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012025701-A1 | ALPHA, ALPHA - DI SUBSTITUTED GLYCINE ESTER DERIVATIVES AND THEIR USE AS HDAC INHIBITORS | CHROMA THERAPEUTICS LTD. (GB) | 2012-03-01 | — | — | WO | disclosed |